Division of Prescription Drugs
Director: Judy McMeekin, Pharm.D. (acting)
Team Leader, Compounding and Pharmacy Practices Team: Pamela Lee, J.D., P.A.
Team Leader, Regulatory Status and Labeling Team: Kim Simmons, J.D., R.Ph.
Team Leader, Marketed Unapproved Drugs Enforcement Team: Leyla Rahjou-Esfandiary, Pharm.D. (acting)
Project Management Officer: Kelisha Turner, MS, CMQ/OE
The Division of Prescription Drugs is responsible for directing inspections and investigations and recommending, directing and/or coordinating case development and compliance actions relating to prescription drug products; providing enforcement and litigation support and guidance for prescription drug products; providing guidance relating to drug establishment registration and drug product listing regulations and regulatory status of domestic and imported drug products marketed in the U.S.
DPD uses risk-based assessments to identify and prioritize unapproved prescription drugs for regulatory action and develops compliance strategies to address violations; and reviews and develops legislative proposals and implementing regulations, policy and guidance documents, enforcement strategies, and outreach activities related to prescription drugs.
For additional information, please visit: